165282-30-4

Upstream product

• 64-17-5 ethanol 
• 165282-29-1 O^1.3,O^4.3-diallyl N^2.1,N^6.1-di-Cbz-L-lysylglycyl-L-aspartate 
• 83173-67-5 N_α,N_ξ-di-Cbz-L-lysine ethyl ester 
• 13567-34-5 N_α,N_ξ-di-Cbz-L-lysylglycine ethyl ester 

Downstream Products

• 165282-32-6 O^5.5-ethyl dihydrogen N^2.1,N^6.1-di-Cbz-L-lysylglycyl-α-L-aspartyl-α-L-glutamyl-α-L-glutamyl-L-seryl-L-leucyl-L-alaninamide 
• 165282-31-5 O^1.4-ethyl dihydrogen N^2.1,N^6.1-di-Cbz-L-lysylglycyl-α-L-aspartyl-L-glutamate 

Relevant academic research and scientific papers

Pilot-scale enzymatic synthesis of bioactive oligopeptides in eutectic-based media

The bioactive peptide precursors Nα-Cbz-L-Lys(Nζ-Cbz)-Gly-OEt (1), Nα-Cbz-L-Lys(Nζ-Cbz)-Gly-L-Asp(OAll)-OAll (2), and Nα-Cbz-L-Lys(Nζ-Cbz)-Gly-L-Asp(OAll)-L-Glu (OAll)OEt (3) were synthesiz

Enzymatic oligopeptide synthesis using a minimal protection strategy: Sequential assembly of a growing oligopeptide chain

An approach to the enzymatic synthesis of oligopeptides is described which relies upon the selectivities of the enzymes employed rather than on the differential protection of the substrates for obtaining the desired sequences. Serine and cysteine protease